Hashida M - Search Results

1

The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration.

Verbaan FJ, Oussoren C, van Dam IM, Takakura Y, Hashida M, Crommelin DJ, Hennink WE, Storm G. Verbaan FJ, et al. Among authors: hashida m. Int J Pharm. 2001 Feb 19;214(1-2):99-101. doi: 10.1016/s0378-5173(00)00642-6. Int J Pharm. 2001. PMID: 11282245

2

Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes.

Verbaan F, van Dam I, Takakura Y, Hashida M, Hennink W, Storm G, Oussoren C. Verbaan F, et al. Among authors: hashida m. Eur J Pharm Sci. 2003 Dec;20(4-5):419-27. doi: 10.1016/j.ejps.2003.09.005. Eur J Pharm Sci. 2003. PMID: 14659486

3

The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.

Kawabata K, Takakura Y, Hashida M. Kawabata K, et al. Among authors: hashida m. Pharm Res. 1995 Jun;12(6):825-30. doi: 10.1023/a:1016248701505. Pharm Res. 1995. PMID: 7667185

4

Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine).

Hashida M, Takemura S, Nishikawa M, Takakura Y. Hashida M, et al. J Control Release. 1998 Apr 30;53(1-3):301-10. doi: 10.1016/s0168-3659(97)00263-0. J Control Release. 1998. PMID: 9741938

5

Cell-specific delivery of genes with glycosylated carriers.

Hashida M, Nishikawa M, Yamashita F, Takakura Y. Hashida M, et al. Adv Drug Deliv Rev. 2001 Nov 19;52(3):187-96. doi: 10.1016/s0169-409x(01)00209-5. Adv Drug Deliv Rev. 2001. PMID: 11718943 Review.

6

Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor.

Nagayama S, Ogawara K, Minato K, Fukuoka Y, Takakura Y, Hashida M, Higaki K, Kimura T. Nagayama S, et al. Among authors: hashida m. Int J Pharm. 2007 Feb 1;329(1-2):192-8. doi: 10.1016/j.ijpharm.2006.08.025. Epub 2006 Aug 30. Int J Pharm. 2007. PMID: 17005341

7

In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes.

Mahato RI, Kawabata K, Takakura Y, Hashida M. Mahato RI, et al. Among authors: hashida m. J Drug Target. 1995;3(2):149-57. doi: 10.3109/10611869509059214. J Drug Target. 1995. PMID: 7496728

8

[Control of in vivo characteristics of gene and antisense DNA disposition].

Takakura Y, Miyao T, Kawabata K, Hashida M. Takakura Y, et al. Among authors: hashida m. Gan To Kagaku Ryoho. 1994 Feb;21(3):320-4. Gan To Kagaku Ryoho. 1994. PMID: 7509150 Japanese.

9

Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.

Takakura Y, Hashida M. Takakura Y, et al. Among authors: hashida m. Crit Rev Oncol Hematol. 1995 Mar;18(3):207-31. doi: 10.1016/1040-8428(94)00131-c. Crit Rev Oncol Hematol. 1995. PMID: 7695833 Review. No abstract available.

10

Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.

Takakura Y, Hashida M. Takakura Y, et al. Among authors: hashida m. Pharm Res. 1996 Jun;13(6):820-31. doi: 10.1023/a:1016084508097. Pharm Res. 1996. PMID: 8792417 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters